EOLO PHARMA Announces Regulatory Clearance To Initiate Phase 1 Study Of MVD1 For Obesity And Type 2 Diabetes
EOLO PHARMA announced that it has received approval to initiate a Phase 1 clinical trial for MVD1, the company’s investigational small molecule designed to reduce